EirGenix (6589) - Cash Flow Conversion Efficiency

Latest as of June 2025: -0.020x

Based on the latest financial reports, EirGenix (6589) has a cash flow conversion efficiency ratio of -0.020x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$-168.94 Million ≈ $-5.32 Million USD) by net assets (NT$8.46 Billion ≈ $266.59 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Review 6589 free cash flow debt coverage to assess the company's free cash flow relative to its total liabilities.

EirGenix - Cash Flow Conversion Efficiency Trend (2017–2024)

This chart illustrates how EirGenix's cash flow conversion efficiency has evolved over time, based on yearly financial data. Also see 6589 market cap for the company's overall valuation and market capitalisation.

EirGenix Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of EirGenix ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Dexterra Group Inc TO:DXT	0.148x
Anshan Senyuan Road Bridge SHE:300210	0.026x
Suzhou Kingswood Printing Ink Co Ltd SHE:300192	0.010x
Hovnanian Enterprises Inc NYSE:HOV	-0.081x
IntelliEPI Cayman TWO:4971	0.031x
MiMedx Group Inc NASDAQ:MDXG	0.123x
Just Dial Limited NSE:JUSTDIAL	0.023x
China Fortune Land Development Co Ltd SHG:600340	0.076x

Annual Cash Flow Conversion Efficiency for EirGenix (2017–2024)

The table below shows the annual cash flow conversion efficiency of EirGenix from 2017 to 2024. View 6589 stock price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	NT$9.26 Billion ≈ $291.69 Million	NT$-311.44 Million ≈ $-9.81 Million	-0.034x	+60.29%
2023-12-31	NT$10.02 Billion ≈ $315.61 Million	NT$-848.56 Million ≈ $-26.73 Million	-0.085x	-513.43%
2022-12-31	NT$10.68 Billion ≈ $336.57 Million	NT$-147.52 Million ≈ $-4.65 Million	-0.014x	-381.65%
2021-12-31	NT$10.43 Billion ≈ $328.56 Million	NT$-29.90 Million ≈ $-941.98K	-0.003x	+98.70%
2020-12-31	NT$1.91 Billion ≈ $60.04 Million	NT$-419.26 Million ≈ $-13.21 Million	-0.220x	+7.36%
2019-12-31	NT$3.30 Billion ≈ $104.01 Million	NT$-784.07 Million ≈ $-24.70 Million	-0.237x	-6.49%
2018-12-31	NT$2.09 Billion ≈ $65.77 Million	NT$-465.61 Million ≈ $-14.67 Million	-0.223x	-34.68%
2017-12-31	NT$1.14 Billion ≈ $36.07 Million	NT$-189.57 Million ≈ $-5.97 Million	-0.166x	--

About EirGenix

TWO:6589 Taiwan Biotechnology

Market Cap

$632.48 Million

NT$20.08 Billion TWD

Market Cap Rank

#11110 Global

#390 in Taiwan

Share Price

NT$66.40

Change (1 day)

+0.00%

52-Week Range

NT$66.40 - NT$66.40

All Time High

NT$188.50